Clinical Trials Directory

Trials / Completed

CompletedNCT02816697

Implementation of a System-level Tobacco Treatment Intervention

Implementation of a System-level Tobacco Treatment Intervention in Thoracic Oncology

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
263 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.

Detailed description

In particular the study aims to see if participants are asked about their smoking status and what services are offered if someone indicates being a former or current smoker. Findings from this study will help improve a standard of care at this clinic and allow us to understand what type of tobacco treatment services are preferred by patients. * Adaption of CEASE will entail exit interviews with patients and individual interviews with clinical staff to identify and address facilitators and barriers to the implementation process. * Effectiveness of CEASE will be measured through questionnaires \& biochemical verification of smoking status using a pre-test/post-test study design before (usual care)and after implementation (CEASE)

Conditions

Interventions

TypeNameDescription
OTHERCEASE* Clinical and Community Effort Against Secondhand Smoke Exposure (CEASE) * CEASE is a system-level intervention that integrates tobacco-use screening, cessation assistance, and referral to outside services into routine visits
OTHERUsual Care Tobacco Treatment Services

Timeline

Start date
2016-06-01
Primary completion
2022-12-01
Completion
2026-04-01
First posted
2016-06-28
Last updated
2026-04-16

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02816697. Inclusion in this directory is not an endorsement.